Buy Pure Inosine for Cell Metabolism Improvement CAS 58-63-9

CAS:58-63-9
Name:Inosine
Formula:C10H12N4O5
Molecular Weight:268.26
Synonyms:
iso-prinosine;Inosine (8CI,9CI);hypoxanthine-ribose;.beta.-Inosine;Inosina [INN-Spanish];9-.beta.-D-Ribofuranosylhypoxanthine;Hypoxanthine 9-beta-D-ribofuranoside;Oxiamin;556-08-1;Hypoxanthine,hypoxanthine-9;
EINECS:200-390-4
Density:2.085 g/cm3
Melting Point:222-226 °C (dec.)(lit.)
Boiling Point:732.815 °C at 760 mmHg
Flash Point:396.993 °C
Solubility:2.1 g/100 mL (20 °C) in water
Appearance:White crystalline powder
Assay: 99%
Package: customer requirements
Storage: Stored in cool, dry and ventilated places, kept far from fire
Application: Used as a coenzyme drugs regulate immune function class

Description

Inosine is a nucleoside that is formed when hypoxanthine is attached to a ribose ring (also known as aribofuranose) via a β-N9-glycosidic bond.

Inosine is commonly found in tRNAs and is essential for proper translation of the genetic code in wobble base pairs.

Knowledge of inosine metabolism has led to advances in immunotherapy in recent decades. Inosine monophosphate is oxidised by the enzyme inosine monophosphate dehydrogenase, yielding xanthosine monophosphate, a key precursor in purine metabolism. Mycophenolate mofetil is an anti-metabolite, anti-proliferative drug that acts as an inhibitor of inosine monophosphate dehydrogenase. It is used in the treatment of a variety of autoimmune diseases including granulomatosis with polyangiitis because the uptake of purine by actively dividing B cells can exceed 8 times that of normal body cells, and, therefore, this set of white cells (which cannot operate purine salvage pathways) is selectively targeted by the purine deficiency resulting from inherited metabolic diseases (IMD) inhibition.

Our Advantage
 



  CAS:58-63-9
Name:Inosine
Formula:C10H12N4O5
Molecular Weight:268.26
Synonyms:
iso-prinosine;Inosine (8CI,9CI);hypoxanthine-ribose;.beta.-Inosine;Inosina [INN-Spanish];9-.beta.-D-Ribofuranosylhypoxanthine;Hypoxanthine 9-beta-D-ribofuranoside;Oxiamin;556-08-1;Hypoxanthine,hypoxanthine-9;
EINECS:200-390-4
Density:2.085 g/cm3
Melting Point:222-226 °C (dec.)(lit.)
Boiling Point:732.815 °C at 760 mmHg
Flash Point:396.993 °C
Solubility:2.1 g/100 mL (20 °C) in water
Appearance:White crystalline powder
Assay: 99%
Package: customer requirements
Storage: Stored in cool, dry and ventilated places, kept far from fire
Application: Used as a coenzyme drugs regulate immune function class

Description

Inosine is a nucleoside that is formed when hypoxanthine is attached to a ribose ring (also known as aribofuranose) via a β-N9-glycosidic bond.

Inosine is commonly found in tRNAs and is essential for proper translation of the genetic code in wobble base pairs.

Knowledge of inosine metabolism has led to advances in immunotherapy in recent decades. Inosine monophosphate is oxidised by the enzyme inosine monophosphate dehydrogenase, yielding xanthosine monophosphate, a key precursor in purine metabolism. Mycophenolate mofetil is an anti-metabolite, anti-proliferative drug that acts as an inhibitor of inosine monophosphate dehydrogenase. It is used in the treatment of a variety of autoimmune diseases including granulomatosis with polyangiitis because the uptake of purine by actively dividing B cells can exceed 8 times that of normal body cells, and, therefore, this set of white cells (which cannot operate purine salvage pathways) is selectively targeted by the purine deficiency resulting from inherited metabolic diseases (IMD) inhibition.

Our Advantage
 



 

POCT Analyzer

The characteristics of POCT devices determine that they can play an important role in primary medical institutions. In order to standardize and strengthen the application of on-site rapid testing in primary medical and health institutions, promote the rational allocation, safe and effective use of POCT in primary medical and health institutions, give full play to its use value, and ensure the healthy development of medical and health services, "On-site Point-of-care Testing (POCT) Primary The Expert Consensus on the Application of Medical and Health Institutions (hereinafter referred to as the "Consensus") came into being. The consensus was published in the 2019 "China Medical Equipment" magazine after first draft writing, 2 expert on-site discussions, 2 expert online review meetings, and 3 submission revisions. The formulation of the consensus will greatly promote the management standards of the POCT industry, continuously increase the training of grass-roots personnel, deeply understand the application requirements of POCT at the grass-roots level, and promote the rapid development of the POCT industry.
Point-of-care testing (POCT) represents a fruitful method in today's hospitals in terms of patient care and cost management. Its application enables some of the testing items originally undertaken by the central laboratory to be transferred to the clinical departments and patient beds that need it. side. For blood gas analysis technology, POCT has shown great advantages.

Our blood gas analyzer is small and portable, beautiful in appearance, accurate in results and good in stability. It is a blood gas analysis platform with both appearance and strength. It can be used not only in the central laboratory department, but also at the bedside of patients to meet the bedside detection needs of clinical departments such as hospital ICU, emergency, anesthesia, respiratory, neurology, etc. It realizes true POCT blood gas analysis and provides more advantageous assistance for clinical practice. Diagnostic Services.

Portable Analyzer for Blood Fat,Home Care Blood Glucose Meter,Best Blood Glucose Meter,Blood Glucose Meter Device

Jilin Sinoscience Technology Co. LTD , https://www.jlgkscience.com